CD34+CD38− AML cell variants are often associated with high peripheral blood and bone marrow leukemic cell counts and adverse genetic abnormalities (e.g., complex karyotype and FLT3 mutations). This evidence concerns the gene CD34 and acute myeloid leukemia.